Why the study?
Does cardioversion maintain sinus rhythm in patients with post-thyrotoxic atrial fibrillation without other heart disease?
Does cardioversion maintain sinus rhythm in patients with post-thyrotoxic atrial fibrillation without other heart disease?
Late cardioversion can successfully maintain long-term sinus rhythm in patients with post-thyrotoxic atrial fibrillation without structural heart disease, suggesting that the absence of structural heart disease is a more important predictor of success than the duration of fibrillation.
Answers are grounded in this paper and cite their sources.
May support late cardioversion in post-thyrotoxic AF without structural disease; challenges duration restrictions but remains hypothesis-generating.
AIMS: As atrial fibrillation is associated with significant mortality and morbidity, restoration of sinus rhythm is desirable. However, previous data suggest that cardioversion should be restricted to patients in whom the fibrillation is of limited duration (<1-2 years) because of high relapse rates. It may be the frequent association with cardiac disease, rather than the duration of fibrillation itself, which determined the high relapse of earlier studies. The aim of this study was to investigate rates of cardioversion, maintenance of sinus rhythm and predictors of subsequent relapse in a homogeneous group of patients without evidence of any co-existent cardiac disease. METHODS AND RESULTS: We report on a retrospective series of 106 patients with thyrotoxicosis-induced fibrillation but no other heart disease: 87% had been in atrial fibrillation for >12 months (median duration 28.5, interquartile range 15-47 months). Cardioversion was attempted using disopyramide and then electric shock. Ninety-eight patients were successfully cardioverted: at late follow-up, 80.6+/-37 months (mean+/-SD), 67% were in sinus rhythm. CONCLUSION: Although a relationship between the duration of fibrillation and maintenance of sinus rhythm was found, the high proportion remaining in sinus rhythm, compared with other series, suggests this influence may be less important than the presence or absence of structural heart disease.
No takes yet. Share an insight, caveat, or question.
H Nakazawa (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: